Your browser doesn't support javascript.
loading
Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load.
Zhao, Lele; Wymant, Chris; Blanquart, François; Golubchik, Tanya; Gall, Astrid; Bakker, Margreet; Bezemer, Daniela; Hall, Matthew; Ong, Swee Hoe; Albert, Jan; Bannert, Norbert; Fellay, Jacques; Grabowski, M Kate; Gunsenheimer-Bartmeyer, Barbara; Günthard, Huldrych F; Kivelä, Pia; Kouyos, Roger D; Laeyendecker, Oliver; Meyer, Laurence; Porter, Kholoud; van Sighem, Ard; van der Valk, Marc; Berkhout, Ben; Kellam, Paul; Cornelissen, Marion; Reiss, Peter; Fraser, Christophe; Ferretti, Luca.
Afiliación
  • Zhao L; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.
  • Wymant C; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.
  • Blanquart F; Centre for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, PSL Research University, Cedex 05, Paris 75231, France.
  • Golubchik T; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.
  • Gall A; European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Cambridge CB10 1SD, UK.
  • Bakker M; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, MB 1007, Netherlands.
  • Bezemer D; Stichting HIV Monitoring, Amsterdam, Amsterdam, AZ 1105, Netherlands.
  • Hall M; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.
  • Ong SH; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK.
  • Albert J; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solna, Stockholm 171 77, Sweden.
  • Bannert N; Division for HIV and Other Retroviruses, Department of Infectious Diseases, Robert Koch Institute, Berlin 13353, Germany.
  • Fellay J; School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne CH-1015, Switzerland.
  • Grabowski MK; Department of Pathology, John Hopkins University, Baltimore, MD 21287, USA.
  • Gunsenheimer-Bartmeyer B; Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin 13353, Germany.
  • Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich CH-8091, Switzerland.
  • Kivelä P; Department of Infectious Diseases, Helsinki University Hospital, Helsinki FI-00029, Finland.
  • Kouyos RD; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich CH-8091, Switzerland.
  • Laeyendecker O; Division of Intramural Research, NIAID, NIH, Baltimore, MD 21205, USA.
  • Meyer L; INSERM CESP U1018, Université Paris Saclay, APHP, Service de Santé Publique, Hôpital de Bicêtre, Le Kremlin-Bicêtre 94270, France.
  • Porter K; Institute for Global Health, University College London, London WC1N 1EH, UK.
  • van Sighem A; Stichting HIV Monitoring, Amsterdam, Amsterdam, AZ 1105, Netherlands.
  • van der Valk M; Stichting HIV Monitoring, Amsterdam, Amsterdam, AZ 1105, Netherlands.
  • Berkhout B; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, MB 1007, Netherlands.
  • Kellam P; Kymab Ltd, Babraham Research Campus, Cambridge CB22 3AT, UK.
  • Cornelissen M; Laboratory of Experimental Virology, Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, MB 1007, Netherlands.
  • Reiss P; Stichting HIV Monitoring, Amsterdam, Amsterdam, AZ 1105, Netherlands.
  • Fraser C; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.
  • Ferretti L; Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford OX3 7LF, UK.
Virus Evol ; 8(1): veac022, 2022.
Article en En | MEDLINE | ID: mdl-35402002
Set-point viral load (SPVL), a common measure of human immunodeficiency virus (HIV)-1 virulence, is partially determined by viral genotype. Epidemiological evidence suggests that this viral property has been under stabilising selection, with a typical optimum for the virus between 104 and 105 copies of viral RNA per ml. Here we aimed to detect transmission fitness differences between viruses from individuals with different SPVLs directly from phylogenetic trees inferred from whole-genome sequences. We used the local branching index (LBI) as a proxy for transmission fitness. We found that LBI is more sensitive to differences in infectiousness than to differences in the duration of the infectious state. By analysing subtype-B samples from the Bridging the Evolution and Epidemiology of HIV in Europe project, we inferred a significant positive relationship between SPVL and LBI up to approximately 105 copies/ml, with some evidence for a peak around this value of SPVL. This is evidence of selection against low values of SPVL in HIV-1 subtype-B strains, likely related to lower infectiousness, and perhaps a peak in the transmission fitness in the expected range of SPVL. The less prominent signatures of selection against higher SPVL could be explained by an inherent limit of the method or the deployment of antiretroviral therapy.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Virus Evol Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Virus Evol Año: 2022 Tipo del documento: Article